By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


H. Lee Moffitt Cancer Center & Research Institute 

12902 Magnolia Drive

Tampa  Florida  33612-9497  U.S.A.
Phone: 888-663-3488 Fax: n/a


Moffitt Cancer Center is …

  • Dedicated to one mission: to contribute to the prevention and cure of cancer.
  • A not-for-profit cancer center created by the Florida Legislature and opened on the campus of the University of South Florida in Tampa in 1986.
  • Named after H. Lee Moffitt, former Speaker of the Florida House of Representatives.
  • One of only 39 cancer center designated by the National Cancer Institute as a Comprehensive Cancer Center.
  • Ranked 13th in the U.S. News & World Report magazine’s “Best Hospitals” list of top cancer centers for 2005
  • A critical resource for the state of Florida, which ranks 2nd in the U.S. in both cancer incidence and mortality.
  • The site of the Bill & Beverly Young National Functional Genomics Center, funded by the U.S. Department of Defense.
  • A major cancer research center with scientific programs in Molecular Oncology; Drug Discovery; Immunology; Experimental Therapeutics; Health Outcomes & Behavior; and Risk Assessment, Detection & Intervention.
  • A center for translational research whose researchers and physicians are committed to improving cancer care by moving discoveries quickly from laboratory bench to patient bedside and into the community.
  • The recipient of more than $50 million annually in sponsored research awards.
  • The largest provider of blood and marrow transplants in the Southeastern U.S.
  • A major economic engine that employed 2,655 people and generated $361 million in direct output in 2005.

Moffitt Cancer Center provides …
  • Compassionate care through more than 200,000 outpatient visits and 6,000 admissions per year on site.
  • Statewide service, impacting 20 percent of cancer cases in Florida through a network of 16 hospital and practice affiliations and more than 400 oncologists.
  • Access to clinical trials – with more than 200 ongoing clinical trials encompassing new and established procedures in chemotherapy, surgery, radiation, and immunotherapy.
  • Screening and prevention services to more than 20,000 people per year, including genetic screening and counseling; smoking cessation programs; clinics for patients at high risk for cancer; mammography and other tests; and a wide array of community education and outreach programs.
  • Comprehensive training, in partnership with the University of South Florida College of Medicine, in all aspects of cancer treatment, research and prevention for medical students, post-graduate fellows, residents, and community physicians.
  • Cancer Answers to anyone with a question related to cancer prevention, early detection, diagnosis, treatment and research via 1-888-MOFFITT, a toll-free information line staffed by registered nurses.

Last Updated: 12-27-2006

Key Statistics

Ownership: Private

Web Site: H. Lee Moffitt Cancer Center & Research Institute

Company News
Rosetta Genomics Ltd. (ROSG) And H. Lee Moffitt Cancer Center & Research Institute Enter Into Agreement To Advance Development Of microRNA-Based Cancer Diagnostic 6/9/2014 9:20:13 AM
H. Lee Moffitt Cancer Center & Research Institute Chooses Digisonics Cardiovascular Information System (CVIS) 5/20/2014 9:47:13 AM
Single Injection May Revolutionize Melanoma Treatment, H. Lee Moffitt Cancer Center & Research Institute Study 8/26/2013 7:29:26 AM
Provectus Pharmaceuticals Inc. Announces H. Lee Moffitt Cancer Center & Research Institute Initiates Phase 1 Study of PV-10 to Elucidate Bystander Effect 1/8/2013 9:45:54 AM
H. Lee Moffitt Cancer Center & Research Institute Researchers and Colleagues Identify PHF20, a Regulator of Gene P53 8/24/2012 7:24:52 AM
H. Lee Moffitt Cancer Center & Research Institute Researchers: Darwin s Principles Say Cancer Will Always Evolve to Resist Treatment 6/22/2012 7:28:23 AM
Body Mass Index Not Linked to Post-Surgical Complications, Survival in Esophageal Adenocarcinoma, H. Lee Moffitt Cancer Center & Research Institute Study 3/28/2012 10:37:38 AM
Potential Solution to Melanoma's Resistance to Vemurafenib, H. Lee Moffitt Cancer Center & Research Institute Study 2/29/2012 7:09:52 AM
H. Lee Moffitt Cancer Center & Research Institute Release: New Patent Promises to Accelerate Cancer Trials 2/15/2012 9:04:16 AM
Ovarian Cancer Risk Related to Inherited Inflammation Genes, H. Lee Moffitt Cancer Center & Research Institute Study 2/8/2012 7:24:57 AM